{
  "docId": "019de073-a93c-766f-ab97-ed6e300b196c",
  "docSlug": "203908938c1628b3b3c60bbc024424ae",
  "documentTitle": "Blue Water Vaccines | Results Presentation Deck | 15 slides",
  "authorId": "blue-water-vaccines",
  "authorName": "Blue Water Vaccines",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 15,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "key_messages",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a93c-766f-ab97-ed6e300b196c/5",
  "deckHref": "/decks/019de073-a93c-766f-ab97-ed6e300b196c",
  "deckJsonHref": "/decks/019de073-a93c-766f-ab97-ed6e300b196c.json",
  "deckAnchorHref": "/decks/019de073-a93c-766f-ab97-ed6e300b196c#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "list",
      "text": "Highly cross-reactive and serotype independent (Conserved surface proteins); Highly immunogenic and elicits: Mucosal Immunity (IgA, Th17, Homed B and T-cells), Systemic Immunity (Opsonic IgG, balanced Th1/Th2); Efficacious against nasopharyngeal colonization, AOM, and pneumonia; Low cost; Easily delivered; Longevity of immune response; Localized long-term memory",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12924704-f83d-4c05-afeb-15311cecee01",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Berild, J. D., Winje, B. A., Vestrheim, D. F., Slotved, H. C., Valentiner-Branth, P., Roth, A., & Storsäter, J. (2020). A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population. Pathogens (Basel, Switzerland), 9(4), 259. https://doi.org/10.3390/pathogens9040259",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1de2595c-5ec9-4bdf-8f04-bc12a57fb010",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Characteristics of an Ideal, Safe, & Effective Vaccine",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bfdc9e1b-fb45-49a3-8e43-7da9196faa92",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 3,
      "beatId": "d485f467-9ded-4226-bcb6-b11af98593b3",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "Slides 3-5 highlight the limitations and challenges of current pneumococcus vaccines",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    },
    {
      "to": 6,
      "from": 5,
      "beatId": "60d3e34a-155c-43ef-bb7f-8f98fe851c8f",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "Slides 5-6 emphasize the need for a more effective solution",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "0c87a956-4acf-45eb-bcd0-90c1b34bd926",
      "evidence": "Slides 3-5 imply the consequences of inaction, highlighting the need for a better solution",
      "position": 0,
      "objective": "What are the consequences of not addressing the limitations of current pneumococcus vaccines?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}